 |
 |
 |
 |
 |
|
|
| Article 1 to 10 out of 351
|
|
-
Thermo Fisher Scientific Announces Collaboration to Establish New Tokyo Biomarker Research Center
(28 Jul 2010)
Thermo Fisher Scientific Inc. announced a collaboration that aims to introduce mass spectrometry-based workflows and technologies into Japan to advance personalized medicine and healthcare. The intent of the collaboration between Thermo ......
-
Thermo Fisher Scientific and Intrinsic Bioprobes Announce Alliance in Mass Spectrometric Immunoassay (MSIA) Workflow Development
(21 Jul 2010)
Thermo Fisher Scientific Inc. and Intrinsic Bioprobes (IBI) Inc. announced an alliance to co-develop and market a mass spectrometry solution that will enable researchers to perform quantitative, high-throughput, high-resolution protein ......
-
Novasep and instrAction enter a worldwide strategic alliance for non-chiral chromatography
(21 Jul 2010)
Novasep and instrAction announced that they have entered a strategic alliance. The alliance will offer customers in the life science industry a combination of instrAction’s proprietary API-selective stationary phases (Instruction® Receptor ......
-
Intana Announces Agreement to Provide Proprietary Spectroscopy Technology
(15 Jul 2010)
Intana Bioscience GmbH announced that it has entered an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V., Beerse, Belgium. Under the agreement, Intana will provide its proprietary ......
-
Roche and IBM Collaborate to Develop Nanopore-Based DNA Sequencing Technology
(02 Jul 2010)
Roche and IBM announced an agreement to develop a nanopore-based sequencer that will directly read and decode human DNA quickly and efficiently. Focused on advancing IBM’s recently published "DNA Transistor” technology, the collaboration will ......
-
caprotec bioanalytics Announces the Successful Completion of a Collaborative Research Project With Roche
(30 Jun 2010)
caprotec bioanalytics GmbH announced that it has successfully completed a research collaboration with F. Hoffmann-La Roche, Basel, Switzerland. Under the collaboration research agreement, caprotec used its proprietary CCMS (Capture Compound ......
-
SIRS-Lab and Analytik Jena cooperate on Sepsis Diagnostics
(17 Jun 2010)
SIRS-Lab GmbH and Analytik Jena AG will be strengthened by working together in the field of molecular sepsis diagnostics. As part of this cooperation, Analytik Jena subsidiary AJ Innuscreen GmbH will provide the partner with a platform for ......
-
Protagen Deepens Cooperation With Bayer Schering Pharma
(11 Jun 2010)
Protagen AG and Bayer Schering Pharma AG announced the closing of a cooperation contract for discovery of novel biomarkers in Endometriosis. Endometriosis is a debilitating gynecological medical condition occuring in roughly 5% -10% of women ......
-
Chip-Man Technologies appoints Ionovation GmbH as German distributor
(18 May 2010)
Customers in Germany now have access to Chip-Man Technologies’ Cell-IQ live cell imaging and analysis platform through life science specialists Ionovation GmbH. Dr Karsten Gall, chief executive officer for Ionovation, explained: "Our focus has ......
-
Epigenomics AG Licenses Biomarker for Colorectal Cancer Blood Test Screening to Canadian Warnex Medical Laboratories
(04 May 2010)
Epigenomics AG and Warnex Medical Laboratories, a division of Warnex Inc., announced that they have signed a non-exclusive licensing agreement for Epigenomics' colorectal cancer biomarker Septin9. Under the terms of the agreement, Warnex has ......
|
|
|
|
|